Characterization of Bone Lesions in Myeloma Before and During Anticancer Therapy Using 18F-FDG-PET/CT and 18F-NaF-PET/CT.

BACKGROUND: The objective of this study was to characterize tumor activity and mineralization status in newly-detected multiple myeloma (MM) bone lesions using 2-18F-fluoro-2-deoxy-D-glucose (18F-FDG)-PET/CT and 18F-sodium fluoride (18F-NaF)-PET/CT before and after antitumor treatment. MATERIALS AND METHODS: In this retrospective study, seven patients with histologically-verified MM were included (four women, three men; median age=57 years, standard deviation=11.23 years). PET/CT was performed with 18F-FDG and with 18F-NaF, both at baseline and after treatment. All patients had positive scans. Volumes of interest (VOIs) were drawn over all 18F-FDG-PET/CT-positive bone lesions, as well as the corresponding regions in 18F-NaF-PET/CT. For characterization of bone lesions, semi-quantitative standard uptake value (SUV) parameters were measured. RESULTS: 18F-FDG-PET/CT in the seven patients detected 39 metabolically active lesions that were correlated with the corresponding sites in 18F-fluoride-PET/CT. Overall, the lesions showed a response to therapy, with a significant decrease in SUVmax on PET/CT using 18F-FDG (p<0.001) and with 18F-NaF (p<0.001). In four patients with a second follow-up scan (at a median of 17 months after baseline scan), there was no significant change in lesion uptake. CONCLUSION: Based on our data, antitumor therapy in MM reduces not only tumor activity, but also the mineralization status of bone lesions. A second follow-up scan in a subset of the cohort yielded no change in mineralization status.

Lossy 3D JPEG2000 compression of abdominal CT images in patients with acute abdominal complaints: effect of compression ratio on diagnostic confidence and accuracy.

PURPOSE: To retrospectively assess the effect of lossy three-dimensional (3D) Joint Photographic Experts Group 2000 (JPEG2000) compression on diagnostic confidence and diagnostic accuracy at emergency abdominal computed tomography (CT). MATERIALS AND METHODS: In this institutional review board-approved study, transverse images from 104 consecutive multidetector CT examinations (section thickness, 3 mm; reconstruction interval, 2 mm) in patients with acute abdominal complaints were subjected to lossy 3D JPEG2000 compression by using three compression ratios (10:1, 12.5:1, and 15:1, with reference to 384 kB [12 bits] as original image size). Three radiologists independently read the original and compressed CT studies. Patient order and compression ratios were randomized, and readers were blinded to that information. For each organ, the presence of compression artifacts, the diagnosis, the confidence in the diagnosis according to a five-point scale, and the confidence about negative findings were noted. All diagnoses were compared with a standard of reference constructed by an abdominal CT expert by using the original images, surgical reports, and patient follow-up data. Logistic regressions, the Friedman test, and analysis of variance were used for statistical analysis. RESULTS: Primary diagnoses were correct in 91.3% (463 of 507), 90.5% (459 of 507), 89.0% (451 of 507) and 90.1% (457 of 507) of the total number of primary diagnoses at 1:1, 1:10, 1:12.5 and 15:1, respectively. These values did not vary significantly (P = .456) with compression ratios. The radiologists' mean confidence about the primary diagnoses was also almost identical at different compression ratios (4.83, 4.87, 4.77, and 4.84 at 1:1, 1:10, 1:12.5 and 15:1, respectively). However, the radiologists' mean confidence about negative findings in the liver was reduced in 50.3% (157 of 312) of studies at 15:1. CONCLUSION: Diagnostic accuracy was not impaired at compression ratios up to 15:1. However, because of the significant reduction of the confidence about negative findings at 15:1, compression ratios no higher than 12.5:1 are recommended.

Clinical Value of 18F-FDOPA PET/CT With Contrast Enhancement and Without Carbidopa Premedication in Patients with Insulinoma.

AIM: We evaluated the clinical usefulness of 6-[18F]fluoro-3,4-dihydroxy-L-phenylalanine(18F-FDOPA)-positron-emission tomography (PET)/computed tomography (CT) in insulinoma detection with contrast enhancement, early acquisition time, and no carbidopa premedication. PATIENTS AND METHODS: Twenty-six patients diagnosed with hyperinsulinemic hypoglycemia underwent an 18F-FDOPA PET/CT examination. Patients without carbidopa premedication and contrast-enhanced CT were included. Imaging findings were compared to the overall final diagnosis (histological findings). RESULTS: In 10 of 26 patients (eight women, two men; mean age=53 years; age range=30-94 years), a detected lesion was confirmed histologically as an insulinoma. 18F-FDOPA PET detected the tumor in five out of ten patients. Contrast-enhanced CT also detected the tumor in five out of ten. Overall, 18F-FDOPA PET/CT, with contrast enhancement and without carbidopa premedication, was able to detect the insulinoma in seven out of ten patients (70%). CONCLUSION: Based on our data, 18F-DOPA PET/CT, with contrast enhancement and without carbidopa premedication, as a 'one-stop' diagnostic modality is a viable option for insulinoma detection.

Influence of PET reconstruction technique and matrix size on qualitative and quantitative assessment of lung lesions on [18F]-FDG-PET: A prospective study in 37 cancer patients.

PURPOSE: To evaluate the influence of point spread function (PSF)-based reconstruction and matrix size for PET on (1) lung lesion detection and (2) standardized uptake values (SUV). METHODS: This prospective study included oncological patients who underwent [18F]-FDG-PET/CT for staging. PET data were reconstructed with a 2D ordered subset expectation maximization (OSEM) algorithm, and a 2D PSF-based algorithm (TrueX), separately with two matrix sizes (168×168 and 336×336). The four PET reconstructions (TrueX-168; OSEM-168; TrueX-336; and OSEM-336) were read independently by two raters, and PET-positive lung lesions were recorded. Blinded to the PET findings, a third independent rater assessed lung lesions with diameters of >4mm on CT. Subsequently, PET and CT were reviewed side-by side in consensus. Multi-factorial logistic regression analyses and two-way repeated measures analyses of variance (ANOVA) were performed. RESULTS: Thirty-seven patients with 206 lung lesions were included. Lesion-based PET sensitivities differed significantly between reconstruction algorithms (P<0.001) and between reconstruction matrices (P=0.022). Sensitivities were 94.2% and 88.3% for TrueX-336; 88.3% and 85.9% for TrueX-168; 67.8% and 66.3% for OSEM-336; and 67.0% and 67.9% for OSEM-168; for rater 1 and rater 2, respectively. SUVmax and SUVmean were significantly higher for images reconstructed with 336×336 matrices than for those reconstructed with 168×168 matrices (P<0.001). CONCLUSION: Our results demonstrate that PSF-based PET reconstruction, and, to a lesser degree, higher matrix size, improve detection of metabolically active lung lesions. However, PSF-based PET reconstructions and larger matrix sizes lead to higher SUVs, which may be a concern when PET data from different institutions are compared.

Clinical Value of 18F-fluorodihydroxyphenylalanine Positron Emission Tomography/Contrast-enhanced Computed Tomography (18F-DOPA PET/CT) in Patients with Suspected Paraganglioma.

AIM: To evaluate (18)F-fluorodihydroxyphenylalanine-positron emission tomography/ contrast-enhanced computed tomography ((18)F-DOPA PET/CT) for the detection of paragangliomas (PARA) without any patient selection, such as genetic predisposition for the development of these tumors, history of metastatic PARA or hormonal status. PATIENTS AND METHODS: In this retrospective study, 28 consecutive patients (15 women, 13 men; mean age=46.4 years; age range=19-73 years), who were referred to our PET/CT center for the detection of clinically suspected PARA, were included. Final diagnosis was confirmed by histological reports of surgically proven lesions and/or clinical follow-up (including laboratory results and/or PET/CT follow-up). RESULTS: On a per-lesion basis (45 lesions) analysis, there was a sensitivity of 64.3% for CT, 73.8% for PET, 100% for PET/CT and a positive predictive value (PPV) of 93.1% for CT, 96.9% for PET and 100% for PET/CT. On a per-patient basis analysis, the sensitivity, specificity and accuracy for CT was 86.7%, 84.6% and 85.7%, respectively, and, for PET 80%, 100% and 89.3%, respectively, and, for PET/CT 100%. CONCLUSION: Based on our data, (18)F-DOPA PET/CT is a "one-stop diagnostic modality" for the assessment of patients with suspected PARA.

Quantitation of microvessel density in squamous cell carcinoma of the head and neck by computer-aided image analysis.

OBJECTIVE: Angiogenesis is the formation of new blood vessels from a preexisting vascular network. In healthy individuals it is normally suppressed and observed only transiently during development, reproduction and wound healing. However, growth, invasion, and metastasis of most solid tumors are dependent on angiogenesis. Without formation of new blood vessels, also termed as neovascularization, tumors cannot exceed a size of about 1 mm3. Therefore, neovascularization is a basic requirement for nutrition and oxygenation of tumor cells. Numerous studies in different solid as well as non-solid tumors have evaluated the prognostic value of tumor neovascularization. In solid tumors the increased microvessel density, the pathological correlate to tumor neovascularization, has been linked to a worse prognosis of the disease. The aim of the current study was to assess the prognostic value of tumor neovascularization for recurrences in squamous cell carcinoma of the head and neck by determining microvessel density. Data was collected using an automated-computerized method and as well as a manual counting method. BASIC RESEARCH DESIGN: Immunohistochemistry was performed to detect intratumoral microvessels in tumor samples of 50 patients with squamous cell carcinoma of the head and neck. We used a monoclonal mouse antibody directed against the CD34 antigen. After immunostaining, the entire tumor section was scanned microscopically at low power (x 40) to identify hot spots, which are the areas of highest neovascularization. Individual tumor microvessels were then counted under high power (x 200) to obtain a vessel count in a defined area, and the average vessel count in 4 hot spots was taken as the microvessel density. Microvessel counting was performed twice by computerized method, as well as manually by two independent investigators without any previous knowledge of patients' pertinent clinical data. Subsequently, both counting techniques were statistically compared with each other. RESULTS: On computer-aided image analysis an increased microvessel density was significantly correlated with recurrence of disease (p = 0.02). Repetitive computer counts yielded similar results (p = 0.08), whereas repeated manual counts by two investigators varied significantly (p = 0.04). However, no further statistical correlations between microvessel density and patients clinical data i.e. tumor status, lymph node status, overall survival, or disease free interval could be found. Furthermore, estimation of overall survival of patients with an increased microvessel density by Kaplan-Meier curves revealed non-significant results. CONCLUSION: There is mounting evidence that suggests, that assessment of tumor neovascularization might provide a novel approach of prognostication in patients with squamous cell carcinomas of the head and neck. In particular, in the present study, the degree of angiogenesis of a tumor, as assessed by microvessel density, was found to be correlated with recurrent disease in squamous cell carcinoma of the head and neck. Computer aided image analysis, an automated technique, constitutes a time-efficient and reproducible technique for quantification of tumor vascularization. We suggest that this computerized microvessel determination could be used as a reliable method for microvessel counts, which, furthermore, seems to be superior to manual counting. However, for a reliable and reproducible assessment of tumor neovascularization, validation procedures and quality control protocols are mandatory.

2MHz ultrasound enhances t-PA-mediated thrombolysis: comparison of continuous versus pulsed ultrasound and standing versus travelling acoustic waves.

In addition to fibrinolytic enzymes, ultrasound has the potential to enhance thrombolysis. High frequency ultrasound has the advantage that a combination of diagnostic and therapeutic ultrasound with only one device is possible. Therefore, we investigated the optimal high frequency (2 MHz) ultrasound field characteristics and application mode in vitro. Continuous ultrasound significantly enhanced rt-PA mediated thrombolysis: in a travelling wave field thrombolysis was augmented by 49.0 +/- 14.7% and in a standing wave field by 34.8 +/- 7.3%. In an intermittent application mode (1Hz, 10Hz, 100Hz, 1kHz) most efficient results were obtained for both wave fields using 1 Hz (46.4 +/- 10.7% and 39.1 +/- 6.6%, respectively). Referring to a possible in vivo application our in vitro data suggests that an intermittent application of a 2 MHz high frequency ultrasound using a travelling wave field would be the most potent application for lysing blood clots.

Correlation between MRI results and intraoperative findings in patients with silicone breast implants.

BACKGROUND: Silicone gel breast implants may silently rupture without detection. This has been the main reason for magnetic resonance imaging (MRI) of the augmented or reconstructed breast. The aim of the present study was to investigate the accuracy of MRI for implant rupture. METHODS: Fifty consecutive patients with 85 silicone gel implants were included in the study. The mean age of the patients was 51 (range 21-72) years, with a mean duration of implantation of 3.8 (range 1-28) years. All patients underwent clinical examination and breast MRI. Intraoperative implant rupture was diagnosed by the operating surgeon. RESULTS: Nineteen of the 50 patients suffered from clinical symptoms. An implant rupture was diagnosed by MRI in 22 of 85 implants (26%). In seven of 17 removed implants (41%), the intraoperative diagnosis corresponded with the positive MRI result. However, only 57% of these patients were symptomatic. Ultrasound imaging of the harvested implants showed signs of interrupted inner layers of the implant despite integrity of the outer shell. By microsurgical separation of the different layers of the implant shell, we were able to reproduce this phenomenon and to produce signs of implant rupture on MRI. CONCLUSION: Our results show that rupture of only the inner layers of the implant shell with integrity of the outer shell leads to a misdiagnosis on MRI. Correlation with clinical symptoms and the specific wishes of the patient should guide the indication for implant removal.

Three-dimensional texture analysis of contrast enhanced CT images for treatment response assessment in Hodgkin lymphoma: comparison with F-18-FDG PET.

PURPOSE: To determine the diagnostic performance of three-dimensional (3D) texture analysis (TA) of contrast-enhanced computed tomography (CE-CT) images for treatment response assessment in patients with Hodgkin lymphoma (HL), compared with F-18-fludeoxyglucose (FDG) positron emission tomography/CT. METHODS: 3D TA of 48 lymph nodes in 29 patients was performed on venous-phase CE-CT images before and after chemotherapy. All lymph nodes showed pathologically elevated FDG uptake at baseline. A stepwise logistic regression with forward selection was performed to identify classic CT parameters and texture features (TF) that enable the separation of complete response (CR) and persistent disease. RESULTS: The TF fraction of image in runs, calculated for the 45° direction, was able to correctly identify CR with an accuracy of 75%, a sensitivity of 79.3%, and a specificity of 68.4%. Classical CT features achieved an accuracy of 75%, a sensitivity of 86.2%, and a specificity of 57.9%, whereas the combination of TF and CT imaging achieved an accuracy of 83.3%, a sensitivity of 86.2%, and a specificity of 78.9%. CONCLUSIONS: 3D TA of CE-CT images is potentially useful to identify nodal residual disease in HL, with a performance comparable to that of classical CT parameters. Best results are achieved when TA and classical CT features are combined.

Puumala virus infection: radiologic findings.

A 33-year-old male patient was admitted to our nephrology department with rapidly deteriorating general health, fever, respiratory difficulties, and acute renal failure. Computed tomography of the thorax revealed interstitial edema with thickening of the interlobular septa, peribronchial cuffing, ground-glass opacities, and small pleural and pericardial effusions. Polymerase chain reaction tests verified Puumala virus infection. The patient recovered with supportive treatment. Hantavirus infection should be considered in the differential diagnosis of young patients who present with acute renal failure of an unknown origin and the nonspecific radiologic finding of noncardiogenic interstitial edema, which in combination with typical clinical symptoms and laboratory parameters, can be indicative of this disease.

Feasibility of texture analysis for the assessment of biochemical changes in meniscal tissue on T1 maps calculated from delayed gadolinium-enhanced magnetic resonance imaging of cartilage data: comparison with conventional relaxation time measurements.

OBJECTIVES: To (1) establish the feasibility of texture analysis for the in vivo assessment of biochemical changes in meniscal tissue on delayed gadolinium-enhanced magnetic resonance imaging of cartilage (dGEMRIC), and (2) compare textural with conventional T1 relaxation time measurements calculated from dGEMRIC data ("T1(Gd) relaxation times"). MATERIALS AND METHODS: We enrolled 10 asymptomatic volunteers (7 men and 3 women; mean age, 27.2 +/- 4.5 years), without a history of meniscus damage, in our study. MRI of the right knee was performed at 3.0 T. An isotropic, 3-dimensional (3D), double-echo steady-state sequences was used for morphologic evaluation, and a dual flip angle 3D gradient echo sequence was used for T1(Gd) mapping. All MRI scans were performed 90 minutes after injection of 0.2 mmol/kg of Gd-diethylenetriamine pentaacetic acid (DTPA), and subsequently, during application of a compressive force (50% of the body weight) in the axial direction. Regions of interest, covering the central portions of the posterior horn of the medial meniscus, were defined on 3 adjacent sagittal sections. Based on the relaxation time maps, mean T1(Gd), as well as the T1(Gd) texture features derived from the co-occurrence matrix (COC: Angular Second Moment, Entropy, Inverse Difference Moment) and wavelet transform (WAV: WavEnLL, WavEnHL, WavEnHH, WavEnLH), were calculated. Paired t tests were used to assess differences between baseline and compression, and intraclass correlation coefficients (ICC) were calculated to establish the intrarater reliability of the measurements. RESULTS: Mean T1(Gd) (-67.3 ms, P = 0.011), Angular Second Moment (-0.0002, P = 0.009), Entropy (+0.033, P = 0.025), WavEnLL (+1011.16, P = 0.002), WavEnHL (+18.64, P = 0.012), and WavEnLH (+72.74, P = 0.035) differed significantly between baseline and compression. Intrarater reliability was substantial for mean T1(Gd) relaxation times (ICC = 0.99-1.0), and also for T1(Gd) co-occurrence matrix (ICC = 0.63-0.92) and WAV (ICC = 0.86-0.98) features. CONCLUSIONS: Texture features extracted from T1 maps calculated from dGEMRIC data are feasible for the in vivo assessment of biochemical changes in the menisci, such as might be induced by mechanical loading. Thus, T1(Gd) texture features complement conventional relaxation time measurements. Further studies are necessary to determine whether the mechanical compression, or a prolonged Gd-DTPA uptake, or both, are responsible for the observed decrease in mean T1(Gd) relaxation times in the menisci.